Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria
Tesidolumab (LFG316) 用于治疗伴有阵发性睡眠性血红蛋白尿的 C5 变异型患者
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2020.265868
Nishimura, Jun-Ichi; Ando, Kiyoshi; Masuko, Masayoshi; Noji, Hideyoshi; Ito, Yoshikazu; Mayer, Jiri; Griskevicius, Laimonas; Bucher, Christoph; Müllershausen, Florian; Gergely, Peter; Rozenberg, Izabela; Schubart, Anna; Chawla, Raghav; Rondeau, Jean-Michel; Roguska, Michael; Splawski, Igor; Keating, Mark T; Johnson, Leslie; Danekula, Rambabu; Bagger, Morten; Watanabe, Yoko; Haraldsson, Börje; Kanakura, Yuzuru